The Epilepsy Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the epilepsy market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Company.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Company Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  
 

Table of Contents

I. Overview
General description of the condition
Symptoms


II. Incidence and Prevalence
Incidence table
Prevalence table

III. Diagnosis
Diagnostic tests

IV. Treatment
Medication
Surgery
Vagus Nerve Stimulation


V. Dosing and Treatment Costs
Dosing for commonly prescribed drugs
Costs for commonly prescribed non-generic drugs


VI. Market Size
Market overview
Sales information for key pharmaceuticals

VII. Comments

VIII. References and Resources